Cargando…
Calcitriol enhances pyrazinamide treatment of murine tuberculosis
BACKGROUND: Tuberculosis is a leading cause of morbidity and mortality in humans worldwide. There is an urgent need for new and effective drugs to treat tuberculosis and shorten the duration of tuberculosis therapy. 1, 25-dihydroxy vitamin D(3) (1,25 (OH)(2)D(3)) has been reported to have a synergis...
Autores principales: | Zhang, Jing, Guo, Ming, Huang, Zhi-Xiang, Bao, Rong, Yu, Qian, Dai, Ming, Wang, Xin, Rao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6793789/ https://www.ncbi.nlm.nih.gov/pubmed/31425356 http://dx.doi.org/10.1097/CM9.0000000000000394 |
Ejemplares similares
-
Should pyrazinamide be preferred in tuberculosis treatment during pregnancy?
por: Karabay, Oguz, et al.
Publicado: (2013) -
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021) -
Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022) -
Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice
por: Almeida, Deepak V., et al.
Publicado: (2014) -
Serum pyrazinamide concentrations in patients with pulmonary tuberculosis
por: Lucena, Stefania de Medeiros Araujo, et al.
Publicado: (2019)